StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Duopharma Biotech Berhad
Kuala Lumpur Stock Exchange:7148.KL
Sector
Location
Market Cap
USD 311.54 M
Share Price
USD 0.32
Avg Daily Volume
574,327
Change (1 day)
1.48%
Change (1 year)
22.27%
Change (YTD)
16.03%
Duopharma Biotech Berhad Total Assets for the year ending December 31, 2024: USD 307.48 M
Duopharma Biotech Berhad Total Assets is USD 307.48 M for the year ending December 31, 2024, a 5.10% change year over year. Total assets are the total value of all assets owned by a company, representing its resources.
-
Duopharma Biotech Berhad Total Assets for the year ending December 31, 2023 was USD 292.57 M, a 5.66% change year over year.
-
Duopharma Biotech Berhad Total Assets for the year ending December 31, 2022 was USD 276.89 M, a -0.73% change year over year.
-
Duopharma Biotech Berhad Total Assets for the year ending December 31, 2021 was USD 278.93 M, a 6.18% change year over year.
-
Duopharma Biotech Berhad Total Assets for the year ending December 31, 2020 was USD 262.70 M, a 17.05% change year over year.
Competitors
GSK plc
USD 19.16
GSK.L
+0.13
0.68%
Haleon plc
USD 5.15
HLN.L
+0.06
1.17%
Jamjoom Pharmaceuticals Factory Company
USD 44.52
4015.SR
-0.69
-1.52%
Joincare Pharmaceutical Group Industry Co.,Ltd.
USD 1.62
600380.SS
+0.06
3.98%
Zhejiang CONBA Pharmaceutical Co.,Ltd.
USD 0.62
600572.SS
+0.00
0.26%
Eli Lilly and Company
USD 780.67
LLY
+1.39
0.18%
Johnson & Johnson
USD 156.01
JNJ
+0.45
0.29%
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Novo Nordisk A/S
USD 71.08
NOVO-B.CO
+2.24
3.26%
Roche Holding AG
USD 347.79
RO.SW
+3.30
0.96%
Novartis AG
USD 123.46
NOVN.SW
+2.11
1.74%
Abbott Laboratories
USD 134.44
ABT
+0.33
0.25%
AstraZeneca PLC
USD 140.96
AZN.L
+1.64
1.18%
Merck & Co., Inc.
USD 80.93
MRK
-1.46
-1.77%
Amgen Inc.
USD 298.24
AMGN
+1.39
0.47%
Pfizer Inc.
USD 25.38
PFE
+0.06
0.24%
Gilead Sciences, Inc.
USD 111.75
GILD
+0.24
0.21%
Sanofi
USD 98.03
SAN.PA
+1.08
1.11%
Vertex Pharmaceuticals Incorporated
USD 459.62
VRTX
+2.59
0.57%
Bristol-Myers Squibb Company
USD 46.92
BMY
-0.71
-1.49%
Key Data
| Date | Total Assets | Accounts Payable | Short-Term Debt | Long-Term Debt |
|---|
Competitors
GSK plc
USD 19.16
GSK.L
+0.13
0.68%
Haleon plc
USD 5.15
HLN.L
+0.06
1.17%
Jamjoom Pharmaceuticals Factory Company
USD 44.52
4015.SR
-0.69
-1.52%
Joincare Pharmaceutical Group Industry Co.,Ltd.
USD 1.62
600380.SS
+0.06
3.98%
Zhejiang CONBA Pharmaceutical Co.,Ltd.
USD 0.62
600572.SS
+0.00
0.26%
Eli Lilly and Company
USD 780.67
LLY
+1.39
0.18%
Johnson & Johnson
USD 156.01
JNJ
+0.45
0.29%
AbbVie Inc.
USD 189.28
ABBV
-1.47
-0.77%
Novo Nordisk A/S
USD 71.08
NOVO-B.CO
+2.24
3.26%
Roche Holding AG
USD 347.79
RO.SW
+3.30
0.96%
Novartis AG
USD 123.46
NOVN.SW
+2.11
1.74%
Abbott Laboratories
USD 134.44
ABT
+0.33
0.25%
AstraZeneca PLC
USD 140.96
AZN.L
+1.64
1.18%
Merck & Co., Inc.
USD 80.93
MRK
-1.46
-1.77%
Amgen Inc.
USD 298.24
AMGN
+1.39
0.47%
Pfizer Inc.
USD 25.38
PFE
+0.06
0.24%
Gilead Sciences, Inc.
USD 111.75
GILD
+0.24
0.21%
Sanofi
USD 98.03
SAN.PA
+1.08
1.11%
Vertex Pharmaceuticals Incorporated
USD 459.62
VRTX
+2.59
0.57%
Bristol-Myers Squibb Company
USD 46.92
BMY
-0.71
-1.49%